[F-18]FDDNP microPET imaging correlates with brain Aβ burden in a transgenic rat model of Alzheimer disease: effects of aging, in vivo blockade, and anti-Aβ antibody treatment.
about
Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerizationNeuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders.A review of β-amyloid neuroimaging in Alzheimer's disease.The Effects of Physiological and Methodological Determinants on 18F-FDG Mouse Brain Imaging Exemplified in a Double Transgenic Alzheimer Model.Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.Modeling Alzheimer's disease in transgenic ratsParallel age-associated changes in brain and plasma neuronal pentraxin receptor levels in a transgenic APP/PS1 rat model of Alzheimer's disease.Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases.Postmortem 3-D brain hemisphere cortical tau and amyloid-β pathology mapping and quantification as a validation method of neuropathology imaging.Comparative evaluation of Logan and relative-equilibrium graphical methods for parametric imaging of dynamic [18F]FDDNP PET determinationsThe role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI.Targeting Neuronal Networks with Combined Drug and Stimulation Paradigms Guided by Neuroimaging to Treat Brain Disorders.Alzheimer's disease biomarkers in animal models: closing the translational gap.Molecular tweezers for lysine and arginine - powerful inhibitors of pathologic protein aggregation
P2860
Q27307991-483F1520-BCFF-40B4-BCB6-28F345610FBEQ30680866-049E1B18-22F5-44FB-AE38-E575F294C878Q30870063-6FC98C7F-896E-4978-8883-D1C8D11660A3Q33795218-9A2D3BB8-9C8D-405B-9D29-DAE8C56CA688Q34441815-D759420E-B878-4AC0-B0E0-397D9B250BBFQ34508624-A6D6D49C-4F0D-4FD0-A09D-5203FA34F89CQ35071220-4391A2DD-4812-47FC-9C6F-579561F6D80DQ36468755-A010F10E-6295-4C2B-8478-1B3E13509355Q36944895-59DF69CD-E538-46AE-AFAC-6003167357EDQ37365063-B3472ADF-5788-4AE3-B3F9-1AA7787E0434Q38217493-F3D031E3-515B-4A64-909E-3A20D66E5DD7Q38543475-C9861577-B17E-44D1-BD1C-FDBEFB650176Q41822193-02010C3B-DCE3-4442-8B65-69A108EE35E7Q42394229-A3FDB2DA-74D1-4ABC-930B-4B212873BB5D
P2860
[F-18]FDDNP microPET imaging correlates with brain Aβ burden in a transgenic rat model of Alzheimer disease: effects of aging, in vivo blockade, and anti-Aβ antibody treatment.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
[F-18]FDDNP microPET imaging c ...... nd anti-Aβ antibody treatment.
@ast
[F-18]FDDNP microPET imaging c ...... nd anti-Aβ antibody treatment.
@en
type
label
[F-18]FDDNP microPET imaging c ...... nd anti-Aβ antibody treatment.
@ast
[F-18]FDDNP microPET imaging c ...... nd anti-Aβ antibody treatment.
@en
prefLabel
[F-18]FDDNP microPET imaging c ...... nd anti-Aβ antibody treatment.
@ast
[F-18]FDDNP microPET imaging c ...... nd anti-Aβ antibody treatment.
@en
P2093
P2860
P1476
[F-18]FDDNP microPET imaging c ...... and anti-Aβ antibody treatment
@en
P2093
Dorothy G Flood
Edmond Teng
Fusheng Yang
Gary W Small
Graham B Cole
Gregory M Cole
Jorge R Barrio
Mychica R Jones
Nagichettiar Satyamurthy
P2860
P304
P356
10.1016/J.NBD.2011.05.003
P577
2011-05-13T00:00:00Z